UK markets closed

Claritas Pharmaceuticals, Inc. (CLAZF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0001+0.0001 (+9,900.00%)
As of 09:52AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 365.00
Enterprise value 365.00
Trailing P/E 0.11
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.00
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.39

Trading information

Stock price history

Beta (5Y monthly) 1.95
52-week change 30.00%
S&P500 52-week change 328.04%
52-week high 30.0002
52-week low 30.0000
50-day moving average 30.0000
200-day moving average 30.0000

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 536.59M
Implied shares outstanding 666.47B
Float 830.44M
% held by insiders 10.26%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 323 Jul 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)30 Sept 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)2.77%
Return on equity (ttm)65.09%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)1.8M
Diluted EPS (ttm)0.0900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2k
Total cash per share (mrq)0
Total debt (mrq)538k
Total debt/equity (mrq)16.40%
Current ratio (mrq)1.42
Book value per share (mrq)0.09

Cash flow statement

Operating cash flow (ttm)-953k
Levered free cash flow (ttm)-10.71M